Molecular Cancer Therapeutics

Molecular Cancer Therapeutics

ISSNs: 1535-7163

Additional searchable ISSN (Electronic): 1538-8514

American Association for Cancer Research, United States

Scopus rating (2021): CiteScore 9.6

Journal

Journal Metrics

Research Output

  1. 2016
  2. Upregulation of AKT3 confers resistance to the AKT Inhibitor MK2206 in breast cancer

    Stottrup, C., Tsang, T. & Chin, Y. R., 1 Aug 2016, In: Molecular Cancer Therapeutics. 15, 8, p. 1964-1974

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review

    Scopus citations: 30
    Check@CityULib
  3. 2015
  4. Gene knockdown by EpCAM aptamer-siRNA chimeras suppresses epithelial breast cancers and their tumor-initiating cells

    Gilboa-Geffen, A., Hamar, P., Le, M. T., Wheeler, L. A., Trifonova, R., Petrocca, F., Wittrup, A. & 1 others, Lieberman, J., 1 Oct 2015, In: Molecular Cancer Therapeutics. 14, 10, p. 2279-2291

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review

    Scopus citations: 49
    Check@CityULib
  5. 2006
  6. Inhibition of human nasopharyngeal carcinoma growth and metastasis in mice by adenovirus-associated virus-mediated expression of human endostatin

    Li, X., Li, C. Y., Li, X., Ding, Y., Chan, L. L., Yang, P., Li, G. & 7 others, Liu, X., Lin, J. S., Wang, J., He, M., Kung, H., Lin, M. C. & Peng, Y., May 2006, In: Molecular Cancer Therapeutics. 5, 5, p. 1290-1299

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review

    Scopus citations: 38
    Check@CityULib